Heart Health
Metal Chelation Therapy
Deep Purification × Metabolic Detox × Renewed Energy
重金屬螯合點滴
Addressing the burden of metal accumulation—from environmental exposure to physiological stress.
In modern life, heavy metals (such as lead, mercury, and cadmium) are difficult for the body to metabolize. They often accumulate through air pollution, diet, or daily habits, posing a potential threat to wellness.
Metal Chelation Therapy uses a science-backed protocol under professional medical supervision. Chelating agents help bind and remove metal ions from tissues, supporting detoxification, metabolic balance, and renewed vitality.
What Is Metal Chelation Therapy?
This treatment involves intravenous administration of chelating agents (such as EDTA or DMSA), which bind to metal deposits in the body and convert them into forms that can be safely excreted. It is complemented with antioxidants and essential minerals to reduce oxidative stress and support recovery.
Clinically efficient, highly bioavailable, and medically monitored, it’s a leading choice for systemic detoxification.
Key Components & Benefits
Chelating Agents (e.g., EDTA, DMSA) | Bind & Remove Metals
-
These compounds form stable complexes with metal ions in the bloodstream or tissues, facilitating safe excretion through urine.
-
Supported by studies showing significant reduction in lead, mercury, and other toxic metal levels.
Antioxidant Vitamins (C, E) | Cellular Protection
-
Added to neutralize free radicals and mitigate oxidative stress during the chelation process.
Essential Minerals (Zinc, Magnesium) | Maintain Homeostasis
-
Replenished to counterbalance the potential loss of beneficial minerals during chelation.
Who Is It For?
-
Individuals with prolonged exposure to metal-containing environments (e.g., industry, agriculture, or dentistry)
-
Those diagnosed with metal toxicity under medical guidance
-
Individuals seeking assisted detoxification and metabolic renewal
-
People concerned with long-term cognitive and cardiovascular wellness
-
Those experiencing unexplained fatigue, “brain fog,” or low energy
Frequently Asked Questions
Chelation therapy involves intravenous administration of chelating agents such as EDTA, DMSA, or DMPS. These agents bind to harmful heavy metals in the body, including lead, mercury, arsenic, and cadmium, which are then excreted through the urine. This process helps reduce the toxic burden in the body.
Recommended Evaluation for the Following Groups
-
Individuals with long-term exposure to high levels of lead or mercury (e.g., battery manufacturing, metal processing, painting, aquaculture).
-
Those frequently consuming seafood, using cosmetics, or drinking water from uncertain sources.
-
People experiencing unexplained symptoms such as chronic fatigue, memory decline, or immune dysfunction.
-
Women of childbearing age with potential heavy metal exposure risks.
-
The number of sessions depends on individual heavy metal levels, exposure history, and overall health, and should be assessed and planned by a physician. Each session usually lasts 1–1.5 hours, with a total of several to dozens of sessions depending on individual needs.
Therapeutic outcomes vary depending on individual constitution and cumulative exposure levels. Multiple sessions are usually required to observe noticeable improvements. Regular monitoring of heavy metal levels in urine or blood is recommended to track progress.
-
On the day of treatment, fatigue may occur. It is recommended to avoid strenuous exercise, hot baths, or swimming,
-
Drink plenty of water to support heavy metal excretion and reduce kidney burden.
-
Mild reactions may include burning at the injection site, nausea, headache, low blood pressure, or changes in kidney function markers. Most of these can be promptly managed and monitored by a physician.
The following groups require physician assessment before treatment:
-
Individuals with impaired kidney function, pregnant or breastfeeding women.
-
Patients with chronic diseases such as cardiovascular disease or diabetes.
-
Those taking anticoagulants or with calcium metabolism disorders.
-
Chelating agents like EDTA, DMSA, or DMPS may also remove essential trace elements such as zinc, magnesium, or calcium. Physicians will provide nutritional supplementation and biochemical monitoring during treatment to maintain safety and balance.
In cases of high heavy metal burden, chelation therapy can reduce oxidative stress and inflammation caused by metals in blood vessels. However, it has not yet been officially approved by the Ministry of Health or international cardiology societies as a standard treatment for cardiovascular disease.
Under professional medical supervision, using approved products and correct procedures is safe. However, self-administering or using unknown sources of chelating agents can lead to serious risks, including kidney failure, low blood calcium, severe allergic reactions, or even life-threatening complications.